EU Rotavirus Vaccine Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : February 2022
  • Region: Europe
  • Country: Other
  • Report ID : 5051

  • Format: PPT, PDF

EU Rotavirus Vaccine Market Analysis: Segmented by Type, Distribution Channel and End User – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5051 Categories: ,

Report Description of the Rotavirus Vaccine Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Substance Abuse Treatment Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Substance Abuse Treatment market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

EU Rotavirus Vaccine Market Executive Summary

The EU Rotavirus Vaccine Market is anticipated to observe a phase of consistent growth, owing to various factors affecting the healthcare sector such as focus of government expenditure towards healthcare sector primarily in research and development accompanied by structural changes introduced into the system to enable several healthcare providers to concentrate not only in ensuring sufficient volume is handled, but also ensuring quality of service is not compromised by healthcare providers.

Market Size and Key Findings

The EU Human Rotavirus Vaccine Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Rotavirus refers to a virus that mostly infects infants & children’s causing diarrhea. This is a contagious virus that shows its symptoms within two or three days of exposure to the virus. Initial symptoms of this infection are fever, vomiting, followed by diarrhea, and abdominal pain. The vaccines are used to help increase the immune system of the body and lowers the severity of an infection. The vaccination starts around six weeks of age and this should be done along with the promoting several activities such as handwashing, clean water, good sanitation, and breastfeeding.

Market Dynamics

Market Growth Drivers Analysis

Major factors for the Europe Human Rotavirus Vaccine market are increase in the awareness regarding vaccines among patients can accelerate the growth of this market. Rise in the population of immunity-compromised individuals can act as a catalyst for the market growth. Increase in the development and manufacturing of vaccine would enhance the market growth.

Market Restraints

Rotavirus therapeutics market is witnessing a substantial decrease in healthcare expenses in most of the advancing countries. This is one of the major reasons that is restraining the human rotavirus vaccine market from growing during the forecast period that will be ending in 2028. The human rotavirus vaccine market is further, witnessing a rise in the prices of the vaccines and the adverse reactions alongside the increased side effects of the vaccine that are further estimated to bar the human rotavirus vaccine market shortly, as a part of the ongoing forecast period of 2021-2028. 

Competitive Landscape

Key Players

Based on the Europe Human Rotavirus Vaccine market, the dominant players segmentation is further segmented is, Merck & Co., Inc.,  GlaxoSmithKline plc, Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd,  BIOVIRx Inc. Biological E,  and others

Products in Pipeline

Other candidate live oral vaccines are in development with the most advanced being RV3, a neonatal strain from Australia that is now in clinical trial. An important and perhaps distinguishing feature of this vaccine has been its good immunogenicity when administered in the newborn period allowing for a birth dose. While rotavirus is less common in the first 2–3 months of life, infants do get rotavirus in this period and a birth dose could further decrease their ultimate risk of disease in their first 5 years of life.

Notable Recent Deals

Biological E announced it had signed a licensing and co-operation agreement, in which Providence had agreed to sell up to 30 million doses of its PTX-COVID 19-B vaccine. Under the agreement, Providence will provide the necessary technology transfer for Biological E to make mRNA drugs in India with a maximum production capacity of 600 million units by 2022 and target a volume of one billion dollars. On July 8, 2021 GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that they have signed a Memorandum of Understanding with the European Commission to provide up to 220,000 doses of sotrovimab, a single dose of SARS-CoV-2 antibody for the treatment of adults and adolescents (elderly 12 years and older and weighing at least 40 kg). ) with COVID-19 which does not require the addition of oxygen and is at risk of further exposure to severe COVID-19. The Joint Procurement Agreement enables European Union (EU) Member States to participate in the immediate purchase of sotrovimab, following urgent local approval or EU-level approval, to treat patients at high risk with COVID-19 who may benefit from early treatment with sotrovimab.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

European Society for Paediatric Infectious Diseases and the European Society for PaediatricGastroenterologyHepatology and Nutrition recommended that rotavirus vaccination be offered to all healthy infants in Europe. Rotavirus vaccination and reimbursement policies from recommending bodies or national health agencies in each country in Europe.

1. Report Description of the EU Rotavirus Vaccine Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. EU Rotavirus Vaccine Market Executive Summary
2.1 US Substance Abuse Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of EU Rotavirus Vaccine market
3.1 Market Growth Drivers Analysis
3.1.1 Increase in the awareness regarding vaccines among patients Significant investment activity
3.1.2 Rise in the population of immunity-compromised individuals
3.1.3 Increase in the development and manufacturing of vaccine
3.1.4 Rise in the geriatric population
3.2 Market Restraints Analysis
3.2.1 Rise in the prices of the vaccines
3.2.2 The adverse reactions alongside the increased side effects of the vaccine
4. Substance Abuse Treatment Market Segmentation
4.1 By Type Analysis:
4.1.1 Alsohol Addiction Treatment
4.1.2 Rotarix
4.1.3 Rotavac
4.1.4 Rotavin M 1
4.1.5 Lanzhou
4.1.6 Others
4.2 By Distribution Channel Analysis:
4.2.1 Drug Stores
4.2.2 Hospital Pharmacies
4.3 By End User Analysis:
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Academic and Research Lab
5. Rotavirus Vaccine Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Research and Assumption
6.2 Products in Pipeline
6.3 R&D Initiatives in EU Rotavirus Vaccine Market
6.4 Notable Recent deals in EU Rotavirus Vaccine Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Merck & Co., Inc. Company overview
Product & Services, Strategies & Financials
7.2 GlaxoSmithKline plc Company overview
Product & Services, Strategies & Financials
7.3 Sanofi Company overview
Product & Services, Strategies & Financials
7.4 Lanzhou Institute of Biologicals Products Co., Ltd
Product & Services, Strategies & Financials
7.5 BIOVIRx Inc. Company overview
Product & Services, Strategies & Financials
7.6 Biological E Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of EU Rotavirus Vaccine Market
9.2 tFuture Opportunities
10. Strategic Recommendations

Substance Abuse Treatment Market Segmentation

By Type:

Based on the Europe Human Rotavirus Vaccine market, the segmentation is further categorized into, rotarix, rotavac, rotavin-M1, lanzhou Lamb, and others

  • Rotarix
  • Rotavac
  • Rotavin M 1
  • Lanzhou Lamb
  • Others

By Distribution channel:

Based on the Europe Rotavirus Vaccine market, the segmentation is further categorized into drug stores and hospital pharmacies

  • Drug Stores
  • Hospital Pharmacies

Based on the Based on Distribution Channel, the market is bifurcated into Retail Pharmacies and Drug Stores, Hospital Pharmacies, and Others.

By End User:

Based on the Europe Human Rotavirus Vaccine market, the segmentation is further categorized into hospitals, clinics, and academic and research lab

  • Hospitals
  • Clinics
  • Academic and Research Lab

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements